• Aucun résultat trouvé

[PDF] Top 20 Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Has 10000 "Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)" found on our website. Below are the top 20 most common "Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)".

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

... provided in the ...Abstract: Coffee is one of the most consumed beverages ...effects in the elderly. People coinfected with human immunodeficiency virus (HIV) and hepatitis C ... Voir le document complet

14

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)

... on patients with chronic hepatitis C which also showed an inverse relationship between coffee intake and the risk of liver fibrosis [ 7 , 31 , 32 ...]. Coffee is a complex mixture of ... Voir le document complet

18

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients

... used in clinical practice in HCV monoinfected patients (25, 26), data on the performance of these tests in HIV- HCV coinfected patients are ... Voir le document complet

24

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

... Consecutive patients seen by six physicians during a 12 months period for a chronic hepatitis C infection (Edouard Herriot and Croix-Rousse hospitals, Lyon, France) and initiating a PEG-IFN/RBV ... Voir le document complet

8

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

... BMI, HCV genotype 3, severe activity and fibrosis in monoinfected ...patients. In HCV monoinfected patients, two distinct forms of steatosis can be observed: “metabolic” ... Voir le document complet

29

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.: Reduced bone mineral density in HIV patients

Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.: Reduced bone mineral density in HIV patients

... ) and for women (median BMD ...loss in the univariable model were included in the multivariable analysis: age, follow-up time since HIV diagnosis, transmission group, AIDS clinical stage, ... Voir le document complet

22

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa

... 17 in HBeAg-positive patients from both our study and others substantially declined during the first twelve months of therapy with no significant difference between anti-HBV treatment ...qHBsAg. ... Voir le document complet

34

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam

... of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? ...#12353] and US National Institute of Drug Abuse [#P30DA011041 & ...the HCV viral ... Voir le document complet

9

Les patients HIV controllers

Les patients HIV controllers

... Les patients appelés HIV controllers sont carac- térisés par l’absence de réplication du VIH détec- table pendant une période très prolongée en l’absence de tout traitement ...Ces patients pourraient ... Voir le document complet

7

Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients.: Glycated hemoglobin in HIV - infected patients

Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients.: Glycated hemoglobin in HIV - infected patients

... HbA1c in HIV-infected subjects with diabetes. Four HIV-infected patients with such inaccurate HbA1c values, possibly due to hemolysis induced by some medications (dapsone, ribavirin, ... Voir le document complet

7

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment

... Method Data from patients whose BOC and TPV trough concen- tration had been assessed during treatment were retrospec- tively analyzed. Plasma concentrations were determined using a LC-MS/MS method. ... Voir le document complet

3

Antiviral therapy in hemodialyzed HCV patients: efficacy, tolerance and treatment strategy

Antiviral therapy in hemodialyzed HCV patients: efficacy, tolerance and treatment strategy

... to HCV infection. The 2 patients who died in the present study suffered from such co-morbidities: one patient had cirrhosis and the other was ... Voir le document complet

27

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.: Non-HDL cholesterol and atherosclerosis in HIV patients.

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.: Non-HDL cholesterol and atherosclerosis in HIV patients.

... increase in non-HDL-C was statistically associated to increased CIMT in univariate analysis only (Table 1), it appears necessary to reach the non-HDL- C goal after the LDL-C goal in HIV+ ... Voir le document complet

38

Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV coinfected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy Running head: HBV profiles and mortality in HIV

Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV coinfected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy Running head: HBV profiles and mortality in HIV

... deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...teaching and research institutions in France or abroad, or from public or private research ... Voir le document complet

42

Comparing methods for assessment of facial dynamics in patients with major neurocognitive disorders

Comparing methods for assessment of facial dynamics in patients with major neurocognitive disorders

... psychological and neuroscientific ...muscles in different terms of action units ...face and the expression apex ...deterministic and probabilistic methodologies including general or special ... Voir le document complet

16

Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials

Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials

... between neurocognitive performance and the QLQ-C30 cognitive functioning ...MOS and the QLQ- C30 as the latter is often and more widely used in clinical ...results in less ... Voir le document complet

8

An approach with serious exergames for assessment and stimulation of patients with neurocognitive disorders

An approach with serious exergames for assessment and stimulation of patients with neurocognitive disorders

... assessment and stimulation of patients with neurocognitive ...clinical and therapeutic approach aiming to create new care for patients with neurocognitive disorders ...physical ... Voir le document complet

2

en
                                                                    fr

en fr Inference in population dynamical models: applications to HIV and to HCV Inference dans les modeles dynamiques de population: applications au VIH et au VHC

... helps in understanding how high is the turnover ...on HIV infected cells turnover. Differences in estimates of half-life of infected long-lived cells as large as those we reported in ... Voir le document complet

165

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

... French HIV treatment centers covering approximately 25% of HIV-infected patients followed in France ...[15]. HCV inci- dence and prevalence data, and HCV treatment ... Voir le document complet

12

Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study

Good acceptability of HIV, HBV, and HCV screening during immigration medical check-up amongst migrants in France in the STRADA study

... shift in the paradigm for HIV testing, moving from patient- initiated testing to provider-initiated testing [ 29 ...change in paradigm ensures that people who would not have come forward for a test ... Voir le document complet

18

Show all 10000 documents...